Key result
Transcriptomic analysis identifies 12 marker genes strongly linked to vascular smooth muscle cell dedifferentiation.
Why the study?
Dedifferentiation of smooth muscle cells causes atherosclerosis and vascular calcification, motivating an integration of multiple microarray datasets to identify relevant marker molecules.
A bioinformatics analysis of microarray datasets identifies 12 key genes involved in smooth muscle cell dedifferentiation, providing potential biomarkers and therapeutic targets for atherosclerosis and vascular calcification.
The dedifferentiation of smooth muscle cells (SMCs) is the main cause of atherosclerosis and vascular calcification. This study integrated the gene expression data of multiple microarrays to identify relevant marker molecules. A total of 72 Gene Expression Omnibus (GEO) samples (GSM) were collected from 10 gene expression data series (GSE) and divided into five groups: non-SMC, SMC, atherosclerotic SMC (SMC-ath), calcified SMC (SMC-calc), and treated SMC (SMC-t). The SMC-t group included synthetic SMCs that had undergone treatment to inhibit proliferation, migration, or inflammation. The gene expression data were merged, normalized, and batch effects were removed before differential gene expression (DGE) analysis was performed via linear models for microarray data (limma) and statistical analysis of metagenomic profiles (STAMPs). The genes with expressions that significantly differed were subsequently subjected to protein-protein interaction (PPI) and functional prediction analyses. In addition, the random forest method was used for classification. Twelve proteins that may be marker molecules for SMC differentiation and dedifferentiation were identified, namely, Proprotein convertase subtilisin/kexin type 1 (PCSK1), Transforming growth factor beta-induced (TGFBI), Complement C1s (C1S), Phosphomannomutase 1 (PMM1), Claudin 7 (CLDN7), Calcium binding and coiled-coil domain 2 (CALCOCO2), SAC3 domain-containing protein 1 (SAC3D1), Natriuretic peptide B (NPPB), Monoamine oxidase A (MAOA), Regulator of the Cell Cycle (RGCC), Alpha-crystallin B Chain (CRYAB), and Alcohol dehydrogenase 1B (ADH1B). Finally, their possible roles in SMCs are discussed. This study highlights the feasibility of bioinformatics analysis for studying SMC dedifferentiation.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2025) studied Atherosclerosis and vascular calcification (smooth muscle cell dedifferentiation) (n=72). Atherosclerotic and calcified conditions vs. Normal smooth muscle cells and non-smooth muscle cells was evaluated on Differentially expressed genes and marker molecules associated with smooth muscle cell dedifferentiation. Integrated differential gene expression analysis of 72 microarray samples identified 12 marker genes, including TGFBI, PCSK1, and RGCC, that strongly correlate with smooth muscle cell dedifferentiation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: